17.41
-0.71(-3.92%)
Currency In USD
| Previous Close | 18.12 |
| Open | 18.11 |
| Day High | 18.13 |
| Day Low | 17.36 |
| 52-Week High | 130 |
| 52-Week Low | 6.76 |
| Volume | 519,457 |
| Average Volume | 1.28M |
| Market Cap | 152.61M |
| PE | 0.01 |
| EPS | 2,537 |
| Moving Average 50 Days | 23.57 |
| Moving Average 200 Days | 27.13 |
| Change | -0.71 |
If you invested $1000 in Tonix Pharmaceuticals Holding Corp. (TNXP) 10 years ago, it would be worth $0 as of November 07, 2025 at a share price of $17.41. Whereas If you bought $1000 worth of Tonix Pharmaceuticals Holding Corp. (TNXP) shares 5 years ago, it would be worth $0.05 as of November 07, 2025 at a share price of $17.41.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tonix Pharmaceuticals to Participate in the Stifel 2025 Healthcare Conference
GlobeNewswire Inc.
Yesterday at 12:00 PM GMT
CHATHAM, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biotechnology company, today announced that Seth Lederman, M.D., Tonix’s Chief Executive O
Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ Rejection
GlobeNewswire Inc.
Nov 04, 2025 12:00 PM GMT
Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first half of 2026 Novel immunomodulatory regimen designed to reduce calcineurin inhibitor exposure and improve
Tonix Pharmaceuticals Announces Presentation at BIO-Europe 2025
GlobeNewswire Inc.
Oct 28, 2025 11:00 AM GMT
CHATHAM, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial biopharmaceutical company announced today that Seth Lederman, M.D., Chief Executive Office